Exhaled nitric oxide and postnatal dexamethasone in chronically ventilator dependent, preterm infants Source: Eur Respir J 2002; 20: Suppl. 38, 532s Year: 2002
Exhaled nitric oxide levels in infants at the age of 6 weeks and 6 months: a prospective birth cohort study Source: Eur Respir J 2006; 28: Suppl. 50, 124s Year: 2006
Smoke exposure, airway symptoms and exhaled nitric oxide in infants: the Generation R study Source: Eur Respir J 2008; 32: 307-313 Year: 2008
Effect of surfactant-BL on efficiency of inhaled nitric oxide therapy in cardiac surgery patients with ARDS Source: Eur Respir J 2005; 26: Suppl. 49, 90s Year: 2005
Combined inhaled nitric oxide and exogenous surfactant-BL therapy in cardiac surgery patients with ARDS Source: Eur Respir J 2005; 26: Suppl. 49, 90s Year: 2005
Non-adherence to inhaled corticosteroid therapy as an explanation for persistently elevated exhaled nitric oxide levels in patients with asthma: Effect of directly observed therapy with inhaled corticosteroids (DOT-ICS) Source: International Congress 2015 – Exhaled biomarkers in monitoring airways disease Year: 2015
Exhaled nitric oxide measured after birth predicts subsequent respiratory infections in infants Source: Eur Respir J 2002; 20: Suppl. 38, 21s Year: 2002
Feasibility of home treatment with inhaled nitric oxide for primary pulmonary hypertension Source: Eur Respir J 2002; 20: Suppl. 38, 598s Year: 2002
Infant exhaled nitric oxide does not identify wheezy children by age of seven years Source: Annual Congress 2010 - Paediatric asthma risk factors Year: 2010
Late Breaking Abstract - Management of asthma in pregnancy using fractional exhaled nitric oxide (FENO) to adjust inhaled corticosteroid (ICS) dose did not improve perinatal outcomes: the Breathing for Life Trial (BLT) Source: Virtual Congress 2020 – Lung function tests and exhaled biomarkers Year: 2020
The relationship between exhaled nitric oxide measurements and subsequent asthma control in a cohort of children followed over 12-months Source: Annual Congress 2011 - Inflammation and genes in childhood asthma Year: 2011
Alterations of exhaled nitric oxide in pre-term infants with chronic lung disease Source: Eur Respir J 2007; 29: 251-258 Year: 2007
The effect of montelukast on lung function and exhaled nitric oxide in infants with early childhood asthma Source: Eur Respir J 2005; 25: 289-294 Year: 2005
Exhaled nitric oxide output is decreased in preterm infants with chronic lung disease in the post-acute phase Source: Eur Respir J 2004; 24: Suppl. 48, 464s Year: 2004
The vasodilator response to inhaled nitric oxide (iNO) predicts the short term evolution with oral vasodilators in pulmonary arterial hypertension Source: Eur Respir J 2001; 18: Suppl. 33, 3s Year: 2001
Effect of once-daily inhaled glucocorticosteroid administration on exhaled nitric oxide in controlled asthma patients Source: Annual Congress 2008 - Pathogenesis and treatment of asthma and COPD Year: 2008
Inhaled fluticasone diproprionate decreases levels of nitric oxide in recurrently wheezy infants Source: Eur Respir J 2003; 22: Suppl. 45, 388s Year: 2003
Comparison of hemodynamic effects of inhaled nitric oxide (iNO) and inhaled epoprostenol (iEPO) in patients with pulmonary hypertension (PH) Source: Annual Congress 2011 - Treatment of pulmonary hypertension Year: 2011
Infant exhaled nitric oxide does not identify persistent wheezers by the age of four years Source: Annual Congress 2006 - Markers of paediatric airway disease Year: 2006
By how much can exhaled nitric oxide vary over three months in children with stable asthma? Source: International Congress 2019 – Paediatric asthma: risk factors, biomarkers and the basics Year: 2019